Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NBIX

Recent news which mentions NBIX

< Previous 1 2 3 4 5 Next >
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Tickers ABSI BLDR BLKB CERE
Tags VRSK Upgrades RBA
From Benzinga
Neurocrine Biosciences Clocks 35% Revenue Growth In Q1, Misses On Bottom-Line Performance
Tickers NBIX
Tags Benzinga Market News Health Care
From Benzinga
Neurocrine Biosciences: Q1 Earnings Insights
Tickers NBIX
Tags Benzinga BZI/Recaps NBIX
From Benzinga
Neurocrine Biosciences's Earnings: A Preview
Tickers NBIX
Tags NBIX BZI/EP Earnings
From Benzinga
3 Pharma Stocks That Could See a Surge in Demand in 2023
Tickers ALNY MRK NBIX
Tags ALNY Market News MRK
From InvestorPlace
What 15 Analyst Ratings Have To Say About Neurocrine Biosciences
Tickers NBIX
Tags NBIX Market News Analyst Ratings
From Benzinga
Expert Ratings for Neurocrine Biosciences
Tickers NBIX
Tags Market News Analyst Ratings NBIX
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
Tickers AMT APLE BCEL CCI
Tags PALI PCTY WM
From Benzinga
3 Growth Stocks That Could Disrupt the Healthcare Industry
Tickers ALNY NBIX SGFY
Tags NASDAQ:NBIX,NYSE:SGFY,NASDAQ:ALNY ALNY Market News
From InvestorPlace
Analyst Expectations for Neurocrine Biosciences's Future
Tickers NBIX
Tags BZI/AAR Benzinga Analyst Ratings
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023
Tickers AIMC ARDX ASAN BILI
Tags TSLA GOVX DEI
From Benzinga
Earnings Scheduled For February 6, 2023
Tickers ACM ACT ALCO AMG
Tags SPG L Benzinga
From Benzinga
Neurocrine Biosciences Earnings Preview
Tickers NBIX
Tags Benzinga Market News Earnings
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
Tickers AGIO AI ALGN APTV
Tags CHRW LSPD Benzinga
From Benzinga
Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing'
Tickers CERE KRTX NBIX
Tags General CERE KRTX
From Benzinga
7 A-Rated Stocks to Buy for Less Than $25
Tickers AAC AACI ABGI ACBA
Tags ARDX NBIX GERN
From InvestorPlace
Why Voyager Therapeutics Stock Is Sinking This Week
Tickers NBIX VYGR
Tags Market News NBIX VYGR
From Motley Fool
Voyager Therapeutics (VYGR) Stock Gains 18% on Gene Therapy Deal
Tickers NBIX VYGR
Tags Market News NASDAQ:VYGR,NASDAQ:NBIX NBIX
From InvestorPlace
Neurocrine Biosciences, Voyager Therapeutics Collaborate For Neurological-Focused Gene Therapies
Tickers NBIX VYGR
Tags Market News Trading Ideas Benzinga
From Benzinga
Have A Look At William Blair's Top Biotech Picks For 2023
Tickers ALBO KDNY KRYS NBIX
Tags Benzinga SGEN Market News
From Benzinga
Despite Neurocrine's Epilepsy Drug Missing Primary Goal In Pediatric Trial, Analyst Sees Strong Growth
Tickers NBIX
Tags Trading Ideas Benzinga Market News
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers ABC ACGL ACM ADP
Tags PERI STRA REYN
From Benzinga
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
Tickers APLS BHVN BIIB CCXI
Tags SWTX NBIX Partner Content
From Benzinga
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
Tickers CTMX ELAN GANX HSKA
Tags HSKA Markets CTMX
From Benzinga
Looking Into Neurocrine Biosciences's Return On Capital Employed
Tickers NBIX
Tags Benzinga NBIX Earnings
From Benzinga
Neurocrine Biosciences: Q3 Earnings Insights
Tickers NBIX
Tags Benzinga Market News Earnings
From Benzinga
Earnings Scheduled For November 1, 2022
Tickers KAI KAMN KAR KKR
Tags PRU USAC NR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
Tickers ABC ACMR ADI AMGN
Tags NTLA RPD CCCC
From Benzinga
3 Top Biotech Stocks Defying the Bear Market
Tickers ALNY NBIX VRTX
Tags VRTX ALNY Recent Press Releases
From Motley Fool
4 Analysts Have This to Say About Neurocrine Biosciences
Tickers NBIX
Tags Benzinga BZI/AAR NBIX
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.